TP53 and breast cancer: Therefore, to directly assess the role of RANKL/RANK in Brca1 mutation-mediated tumorigenesis in vivo, we first deleted Brca1 and p53 in basal mammary epithelial cells and mammary progenitor cells using K5Cre mice16 to induce mammary cancer as previously reported17,18.